OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
BFS technology can help maintain sterility during the biologics manufacturing process.
Both demand for and investment in fill/finish capacity continue to rise.
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
December 02, 2022
The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.
December 01, 2022
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.
November 30, 2022
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 16, 2022
Webinar Date/Time: Wed, Dec 7, 2022 11:00 AM EST
November 15, 2022
By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.
In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.
Through collaboration and transparency, engineering and automation companies can achieve great efficiencies and success for their customer by integrating intelligent design into a facility.
By taking a digital maturity-first approach to Pharma 4.0, manufacturers can optimally position themselves for success.